Physician profile
Paul A Carson
NPI 1679578603
$17,917.78
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $113 · 2021: $125 · 2022: $396 · 2023: $2,516 · 2024: $3,665 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,750 · Food and Beverage: $1,168 · Travel and Lodging: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,750.00 |
| Food and Beverage | $1,168.16 |
| Travel and Lodging | $458.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11,451.63 | 2019-2024 | Xarelto |
| Lilly USA, LLC | $2,750.00 | 2023-2024 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,654.09 | 2022-2024 | Jardiance |
| Pfizer INC. | $426.16 | 2022-2025 | |
| Abbott Laboratories | $266.57 | 2022-2023 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.74 | 2023-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $80.70 | 2023-2024 | Eliquis, Camzyos |
| Ucb, INC. | $66.19 | 2023-2024 | Briviact |
| Mallinckrodt Hospital Products INC. | $38.21 | 2025 | Terlivaz |
| Novo Nordisk INC | $34.38 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.